The latest Investing Matters Podcast with Jean Roche, Co-Manager of Schroder UK Mid Cap Investment Trust has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksMTFB.L Share News (MTFB)

  • There is currently no data for MTFB

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

TRADING UPDATES: Motif Bio takeover called off; Yamana buys at Wasamac

Mon, 14th Jun 2021 20:33

(Alliance News) - The following is a round-up of updates by London-listed companies issued on Monday and not separately reported by Alliance News:

----------

TBC Bank Group PLC - Tbilisi, Georgia-headquartered lender - Says just under 24% of shareholders vote against approval of directors' remuneration report. "The executive remuneration arrangements reported on in the 2020 directors' remuneration report are fully aligned with our directors' remuneration policy, which was approved by 99.9% of our shareholders at our 2018 AGM," lender explains. It continues: "Over the last year, we have engaged with shareholders about executive remuneration in connection with the preparation of the new directors' remuneration policy, which the board notes was approved by 96.2% of shareholders at the AGM. We will continue our active dialogue with shareholders on executive remuneration matters, particularly with those who decided to vote against this resolution, and intend to further consult with shareholders during the coming months to understand their concerns." Also notes 25% of shareholders vote against resolution to disapply statutory pre-emption rights.

----------

Spectra Systems Corp - Rhode Island-based authentication technology provider - Reports lack of quorum at annual general meeting. Notes only 24% of shares voted, which came from 23 ballots.

----------

Cadence Minerals PLC - UK-based mineral resources investor - Says 1% investee Macarthur Minerals o spin-out its non-iron ore assets in the Pilbara into Infinity Mining Ltd. Infinity intends to IPO in Australia. "This strategy will fast track further exploration and the future development potential of the Pilbara Assets and allow Macarthur to focus solely on the development of its flagship iron ore projects situated at Lake Giles in the Yilgarn region of south-western, Western Australia," Macarthur explains.

----------

Braveheart Investment Group PLC - makes strategic investments in companies it thinks will outperform - Notes investee Paraytec's grant funded project to deploy its ActiPix technology in the field of Alzheimer's disease diagnosis is "progressing well". "Prototype instruments are being built, to test blood for protein biomarkers. If successful, these instruments will be used by clinicians aiming to more accurately diagnose patients and monitor their treatment," company adds.

----------

Yamana Gold Inc - gold, silver and copper miner in Canada, Chile, Brazil and Argentina - Agrees to buy the Francoeur, Arntfield and Lac Fortune gold properties adjoining the company's Wasamac project as well as additional claims in the Beuchastel township to the east of the Wasamac project from Globex Mining Enterprises Inc. Will pay CAD4.0 million, about USD3.3 million, in shares to Globex, with remaining CAD11.0 million, payable over 4 years, to be paid in either cash or shares. On top of that, Globex will receive a 2% gross metal royalty from Yamana, of which 0.5% may be bought back at any time by Yamana for CAD1.5 million, following which the royalty would be reduced to a 1.5% gross metal royalty.

----------

Secure Property Development & Investment PLC - eastern Europe focused property investor - Signs three agreements over transfer of certain assets owned by SPDI in Romania and Ukraine to Arcona Property Fund NV. Under the terms of the agreements, SPDI will receive approximately 605,000 new ordinary shares in Arcona and about 145,000 warrants over ordinary shares in Arcona, as well as EUR1 million in cash. Says transaction worth total of EUR8.2 million.

----------

Motif Bio PLC - AIM cash shell - Says BiVictriX Therapeutics Ltd acquisition cancelled after shareholders at annual general meeting vote against several resolutions. As a result, shares will be cancelled from trading on AIM on Tuesday. Has previously proposed name change to BiVictriX Therapeutics and placing and subscription to raise GBP10.1 million via issue of 50.5 million new shares, at a price of 20 pence each. Both of which will now not go ahead.

----------

By Paul McGowan; paulmcgowan@alliancenews.com

Copyright 2021 Alliance News Limited. All Rights Reserved.

More News
1 Apr 2019 16:48

Amphion Innovations Pledges Polarean Shares As Extra Security For Loan (ALLISS)

LONDON (Alliance News) - Amphion Innovations PLC said Monday it has pledged its holding in Polarean Imaging PLC as additional security against its loan facility with its debt in Amphion closed 22%

Read more
20 Mar 2019 10:31

WINNERS & LOSERS SUMMARY: Inmarsat Up As Private Equity Firms Make Bid

LONDON (Alliance News) - The following stocks are the leading risers and fallers within the main London indices on Wednesday.----------FTSE 100 - Group, up 1.1%. The telecommunications was

Read more
19 Mar 2019 16:20

Amphion Innovations Sells More Shares In Motif Bio As Loan Repayment (ALLISS)

LONDON (Alliance News) - Amphion Innovations PLC on Tuesday said it sold 3.3 million shares in its Motif Bio PLC partner company as a partial loan repayment.Amphion Innovations develops and

Read more
18 Mar 2019 11:46

Motif Bio Chair Morgan Stands Down, Williams Becomes Interim Chair

LONDON (Alliance News) - Motif Bio PLC said Monday Chair Richard Morgan had resigned from the biopharmaceutical firm, to be replaced by biopharma veteran Bruce Williams as interim - who also as of

Read more
15 Mar 2019 09:26

Amphion Innovations Sells Partner's Motif Bio Shares In Loan Repayment (ALLISS)

LONDON (Alliance News) - Amphion Innovations PLC on Friday said it sold 1.8 million shares in partner pharmaceutical company Motif Bio PLC to repay a loan facility.Amphion made USD144,000

Read more
11 Mar 2019 18:11

Amphion Innovations Agrees To Amend 2014 Loan Facility (ALLISS)

LONDON (Alliance News) - Amphion Innovations PLC said Monday it has amended its loan facility first agreed in 2014 and then amended last October.Amphion amended the loan interest rate to to

Read more
18 Feb 2019 10:43

WINNERS & LOSERS SUMMARY: Reckitt Rises After Strong Annual Results

LONDON (Alliance News) - The following stocks are the leading risers and fallers within the main London indices on Monday.----------FTSE 100 - WINNERS----------Reckitt its

Read more
18 Feb 2019 09:27

Motif Bio Will Need Fundraise After Agreeing To Repay Part of Loan

LONDON (Alliance News) - Shares in Motif Bio PLC plunged on Monday as its subsidiary, Motif Biosciences Inc signed an amendment agreement with lender Hercules Capital Inc over a loan agreement in

Read more
15 Feb 2019 16:34

Invesco Lowers Motif Bio Interest By More Than 10% (ALLISS)

LONDON (Alliance News) - Motif Bio PLC on Friday said that Invesco Ltd has cut its stake in the company by more than 10%.Prior to Friday's deal, Invesco held a 24.98% interest in the it

Read more
14 Feb 2019 11:47

Motif Bio crashes as FDA calls for more data

(Sharecast News) - Motif Bio said it will need to raise new funds after the application for its skin infections treatment, iclaprim, was refused by the US drug regulator in its present form.

Read more
14 Feb 2019 11:17

WINNERS & LOSERS SUMMARY: ConvaTec Slumps On "Disappointing" Results

LONDON (Alliance News) - The following stocks are the leading risers and fallers within the main London indices on Thursday.----------FTSE 100 - WINNERS----------Micro up

Read more
5 Feb 2019 10:56

Motif Bio Receives GBP36,500 Following Warrants Exercise (ALLISS)

LONDON (Alliance News) - Motif Bio PLC on Tuesday said it has netted GBP36,514 following the exercise of share warrants.The pharmaceutical company said 113,396 warrants were exercised at a

Read more
16 Oct 2018 11:38

Amphion Innovations Restructures Loan And Agrees Further Drawdown

LONDON (Alliance News) - Amphion Innovations PLC on Tuesday said it has restructured its loan payments and agreed a further USD1.1 million draw-down.Amphion's shares dropped 12% to 0.66

Read more
21 Aug 2018 10:50

Amphion Innovations Sells Motif Bio Shares To Repay Loan Facility (ALLISS)

LONDON (Alliance News) - Amphion Innovations PLC said Tuesday it sold 3 million shares in Motif Bio PLC to institutional investors at 33.5 pence each, lowering its stake in the company to company

Read more
8 Aug 2018 12:28

Motif Bio Gets Patent Permission In US For Antibiotic Iclaprim

LONDON (Alliance News) - Motif Bio PLC said Wednesday it has been given a Notice of Allowance from the US Patent & Trademark Office for use of its antibiotic, iclaprim, to treat bacterial that

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.